xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537394 | 45 | Figure S1 | Positive | true | 0.637 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537395 | 45 | Figure S1 | Positive | true | 0.913 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537396 | 45 | Figure S1 | Positive | true | 0.438 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537397 | 45 | Figure S1 | Positive | true | 4.89 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537398 | 45 | Figure S1 | Positive | true | 4.38 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537399 | 45 | Figure S1 | Positive | true | 2.17 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537400 | 45 | Figure S1 | Positive | true | 6.47 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537401 | 45 | Figure S1 | Positive-Low | true | 8750.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537402 | 262 | Figure S1 | Positive | true | 48400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537403 | 263 | Figure S1 | Positive | true | 0.0000236 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537404 | 262 | Figure S1 | Positive | true | 60400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537431 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537432 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537407 | 263 | Figure S1 | Positive | true | 0.0000325 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537433 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537405 | 263 | Figure S1 | Positive | true | 0.0000385 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537406 | 262 | Figure S1 | Positive | true | 356000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537408 | 262 | Figure S1 | Positive | true | 195000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537409 | 263 | Figure S1 | Positive | true | 0.0000855 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537436 | 316 | Figure 3 and S10 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537448 | 190 | Figure 6 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537391 | 437 | Figures 1, S3, S4, Table S1 and PDB 9KVJ | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537410 | 262 | Figure S1 | Positive | true | 48100.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537414 | 262 | Figure S1 | Positive | true | 217000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537411 | 263 | Figure S1 | Positive | true | 0.000236 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537412 | 262 | Figure S1 | Positive | true | 204000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537413 | 263 | Figure S1 | Positive | true | 0.000891 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537416 | 262 | Figure S1 | Positive | true | 70400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537415 | 263 | Figure S1 | Positive | true | 0.000472 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537417 | 263 | Figure S1 | Positive | true | 0.000455 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537434 | 45 | Figures 3, 4 and S12 | Positive | true | 6.83 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537440 | 263 | Figure 4 and S12 | Positive-Low | true | 0.124 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537435 | 45 | Figures 3, 4 and S12 | Positive | true | 7.24 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537438 | 45 | Figures 2, 4, S8 and S12 | Positive-Low | true | 1480.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537439 | 262 | Figure 4 and S12 | Positive-Low | true | 84000.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537444 | 263 | Figures 3, 4 and S12 | Positive | true | 0.000528 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537441 | 262 | Figures 3, 4 and S12 | Positive | true | 165000.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537442 | 263 | Figures 3, 4 and S12 | Positive | true | 0.0012 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537443 | 262 | Figures 3, 4 and S12 | Positive | true | 77200.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537425 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537393 | 45 | Figure S1 and S5 | Positive | true | 0.488 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537419 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537420 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537421 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537422 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537423 | 316 | Figures 1, 3, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537424 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537426 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537427 | 316 | Figure S2 | Positive-Low | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537446 | 600 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537428 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537429 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537430 | 316 | Figure 1 and S2 | Positive-Low | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537447 | 600 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537472 | 262 | Figure S1 | Positive | true | 204000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537484 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537485 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537486 | 316 | Figure S2 | Positive-Low | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537487 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537475 | 263 | Figure S1 | Positive | true | 0.000472 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537504 | 602 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537505 | 600 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537473 | 263 | Figure S1 | Positive | true | 0.000891 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537474 | 262 | Figure S1 | Positive | true | 217000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537490 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537476 | 262 | Figure S1 | Positive | true | 70400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537488 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537489 | 316 | Figure 1 and S2 | Positive-Low | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537491 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537454 | 45 | Figure S1 | Positive | true | 0.637 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537492 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537506 | 600 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537453 | 45 | Figure S1 and S5 | Positive | true | 0.488 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537455 | 45 | Figure S1 | Positive | true | 0.913 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537456 | 45 | Figure S1 | Positive | true | 0.438 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537477 | 263 | Figure S1 | Positive | true | 0.000455 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537493 | 45 | Figures 3, 4 and S12 | Positive | true | 6.83 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537507 | 190 | Figure 6 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537494 | 45 | Figures 3, 4 and S12 | Positive | true | 7.24 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537497 | 45 | Figures 4, S8 and S12 | Positive-Low | true | 1480.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537495 | 316 | Figure 3 and S10 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537458 | 45 | Figure S1 | Positive | true | 4.38 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537452 | 437 | Figures 2, S7, S9, Table S1 and PDB 9KVQ | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537457 | 45 | Figure S1 | Positive | true | 4.89 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537459 | 45 | Figure S1 | Positive | true | 2.17 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537499 | 263 | Figure 4 and S12 | Positive-Low | true | 0.124 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537460 | 45 | Figure S1 | Positive | true | 6.47 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537461 | 45 | Figure S1 | Positive-Low | true | 8750.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537498 | 262 | Figure 4 and S12 | Positive-Low | true | 84000.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537464 | 262 | Figure S1 | Positive | true | 60400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537500 | 262 | Figures 3, 4 and S12 | Positive | true | 165000.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537501 | 263 | Figures 3, 4 and S12 | Positive | true | 0.0012 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537462 | 262 | Figure S1 | Positive | true | 48400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537463 | 263 | Figure S1 | Positive | true | 0.0000236 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537503 | 263 | Figures 3, 4 and S12 | Positive | true | 0.000528 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537465 | 263 | Figure S1 | Positive | true | 0.0000385 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537466 | 262 | Figure S1 | Positive | true | 356000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537502 | 262 | Figures 3, 4 and S12 | Positive | true | 77200.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537470 | 262 | Figure S1 | Positive | true | 48100.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454903 | Epitope of Fab 1C4 on SARS-CoV-2 BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E337, N340, T342, R343, K437, L438, S440, K441, V442, N447, P496 | null | null | 10002661 | UJU86738.1 | E340, N343, T345, R346, K440, L441, S443, K444, V445, N450, P499 | Partial Epitope | null | BCell | 28537478 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.